1. Baldi F, Bianco MA, Nardone G, Pilotto A, Zamparo E. Focus on acute diarrhoeal disease. World J Gastroenterol. 2009; 15:3341–8.
Article
2. Vernacchio L, Vezina RM, Mitchell AA, Lesko SM, Plaut AG, Acheson DW. Diarrhea in American infants and young children in the community setting: incidence, clinical presentation and microbiology. Pediatr Infect Dis J. 2006; 25:2–7.
3. Farthing MJ. Diarrhoea: a significant worldwide problem. Int J Antimicrob Agents. 2000; 14:65–9.
Article
4. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005; 365:1073–86.
Article
5. Thielman NM and Guerrant RL. Clinical practice. Acute infectious diarrhea. N Engl J Med. 2004; 350:38–47.
6. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001; 32:331–51.
Article
7. Cheng AC, McDonald JR, Thielman NM. Infectious diarrhea in developed and developing countries. J Clin Gastroenterol. 2005; 39:757–73.
Article
8. Thapar N and Sanderson IR. Diarrhoea in children: an interface between developing and developed countries. Lancet. 2004; 363:641–53.
9. Gadewar S and Fasano A. Current concepts in the evaluation, diagnosis and management of acute infectious diarrhea. Curr Opin Pharmacol. 2005; 5:559–65.
10. Shin HB, Jeong SH, Kim M, Kim WH, Lee K, Chong Y. Isolation trend of enteropathogenic bacteria in 1969-1998. Korean J Clin Microbiol. 2001; 4:87–95.
11. Korea Center for Disease Control & Prevention. The prevalence and characteristics of bacteria causing acute diarrhea in Korea. 2008. http://www.cdc.go.kr/contents/information/had/b/9918_view.html.
12. Iijima Y, Asako NT, Aihara M, Hayashi K. Improvement in the detection rate of diarrhoeagenic bacteria in human stool specimens by a rapid realtime PCR assay. J Med Microbiol. 2004; 53:617–22.
Article
13. Reller ME, Lema CA, Perl TM, Cai M, Ross TL, Speck KA, et al. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol. 2007; 45:3601–5.
14. Chapela MJ, Fajardo P, Garrido A, Cabado AG, Ferreira M, Lago J, et al. Comparison between a TaqMan polymerase chain reaction assay and a culture method for ctx-positive Vibrio cholerae detection. J Agric Food Chem. 2010; 58:4051–5.
Article
15. Nhung PH, Ohkusu K, Miyasaka J, Sun XS, Ezaki T. Rapid and specific identification of 5 human pathogenic vibrio species by multiplex polymerase chain reaction targeted to dnaJ gene. Diagn Microbiol Infect Dis. 2007; 59:271–5.
Article
16. Daube G, Simon P, Limbourg B, Manteca C, Mainil J, Kaecken-beeck A. Hybridization of 2,659 Clostridium perfringens isolates with gene probes for seven toxins (alpha, beta, epsilon, iota, theta, mu, and enterotoxin) and for sialidase. Am J Vet Res. 1996; 57:496–501.
17. Jang YH, Chung J, Baek S, Park S, Sung H, Kim MN. Implementation of multiplex PCR for species identification and toxin typing in toxigenic Clostridium difficile culture. Korean J Clin Microbiol. 2009; 12:11–6.
18. Paton AW and Paton JC. Multiplex PCR for direct detection of Shiga toxigenic Escherichia coli strains producing the novel sub-tilase cytotoxin. J Clin Microbiol. 2005; 43:2944–7.
19. Kim JS, Lee GG, Park JS, Jung YH, Kwak HS, Kim SB, et al. A novel multiplex PCR assay for rapid and simultaneous detection of five pathogenic bacteria: Escherichia coli O157: H7, Salmonella, Staphylococcus aureus, Listeria monocytogenes, and Vibrio parahaemolyticus. J Food Prot. 2007; 70:1656–62.
20. O'Leary J, Corcoran D, Lucey B. Comparison of the EntericBio multiplex PCR system with routine culture for detection of bacterial enteric pathogens. J Clin Microbiol. 2009; 47:3449–53.
21. Butzler JP. Campylobacter, from obscurity to celebrity. Clin Microbiol Infect. 2004; 10:868–76.
Article
22. Thorney JP, Shaw JG, Gryllos IA, Eley A. Virulence properties of clinically significant Aeromonas species: evidence for pathogenicity. Rev Med Microbiol. 1997; 8:61–72.
23. Choi JP, Lee SO, Kwon HH, Kwak YG, Choi SH, Lim SK, et al. Clinical significance of spontaneous Aeromonas bacterial peritonitis in cirrhotic patients: a matched case-control study. Clin Infect Dis. 2008; 47:66–72.
24. Kang JM, Kim BN, Choi SH, Kim NJ, Woo JH, Ryu J, et al. Clinical features and prognostic factors of Aeromonas bacteremia. Infect Chemother. 2005; 37:161–6.
25. Labbe R. Clostridium perfringens. In: Doyle MP, ed. Foodborne Bacterial Pathogens. New York; Marcel Dekker, Inc. 2006. 191–234.
26. Kokai-Kun JF, Songer JG, Czeczulin JR, Chen F, McClane BA. Comparison of western immunoblots and gene detection assays for identification of potentially enterotoxigenic isolates of Clostridium perfringens. J Clin Microbiol. 1994; 32:2533–9.
Article
27. Lee SW, Lee BK, Lee YJ, Lee HS, Jung SC, Sun KH, et al. A study on epidemiological characteristics and control methods of EHEC infection in Korea. Korean J Epidemiol. 2005; 27:37–52.
28. Oh YH and Kim YB. Use of polymerase chain reaction and serum antibodies for diagnosis of enterohemorrhagic Escherichia coli. J Korean Soc Microbiol. 1998; 33:99–110.